Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective

The objective of the present study was to describe a new model of the cost-effectiveness of treatment of generalized anxiety disorder (GAD) and its application to a comparison of pregabalin versus venlafaxine extended-release (XR) from a Spanish healthcare perspective. Microsimulation techniques, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vera-Llonch, Montserrat, Dukes, Ellen, Rejas, Javier, Sofrygin, Oleg, Mychaskiw, Marko, Oster, Gerry
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816249/
https://www.ncbi.nlm.nih.gov/pubmed/19506926
http://dx.doi.org/10.1007/s10198-009-0160-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816249/
https://www.ncbi.nlm.nih.gov/pubmed/19506926
http://dx.doi.org/10.1007/s10198-009-0160-7

Ejemplares similares